Nalpropion Pharmaceuticals, Inc.
Industry
- Pharmaceuticals
- Biotechnology
Other Names/Subsidiaries
- Currax Pharmaceuticals LLC
- Orexigen Therapeutics, Inc.
Latest on Nalpropion Pharmaceuticals, Inc.
A drug company’s risk of receiving a promotion enforcement letter from the US Food and Drug Administration may increase with corporate mergers and acquisitions and a failure to clear away old advertis
The European Medicines Agency wants to know how many patients worldwide have used Currax Pharmaceuticals ’ weight management drug, Mysimba (naltrexone/bupropion), as part of a safety review it has st
Novo Nordisk Pharma AG ’s Wegovy has been given the green light for EU approval, setting it up to become the firm’s second obesity approval in the region, but its launch will not come until the second
The US Food and Drug Administration’s Office of Prescription Drug Promotion issued six enforcement letters in 2020, just one more than the record low set in 2017. While citations declined they focused